These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33720901)

  • 21. Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.
    Quattrone A; Caligiuri ME; Morelli M; Nigro S; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Vaccaro MG; Sabatini U; Vescio V; Stanà C; Rocca F; Caracciolo M; Quattrone A
    Parkinsonism Relat Disord; 2019 Jun; 63():124-130. PubMed ID: 30803901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semantic and phonemic verbal fluency in Parkinson's disease: Influence of clinical and demographic variables.
    Obeso I; Casabona E; Bringas ML; Alvarez L; Jahanshahi M
    Behav Neurol; 2012; 25(2):111-8. PubMed ID: 22530265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
    Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA
    Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.
    Warmuth-Metz M; Naumann M; Csoti I; Solymosi L
    Arch Neurol; 2001 Jul; 58(7):1076-9. PubMed ID: 11448296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.
    Mueller C; Hussl A; Krismer F; Heim B; Mahlknecht P; Nocker M; Scherfler C; Mair K; Esterhammer R; Schocke M; Wenning GK; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Sep; 54():90-94. PubMed ID: 29643007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between qualitative balance indices, dynamic posturography and structural brain imaging in patients with progressive supranuclear palsy and its subtypes.
    Pasha SA; Yadav R; Ganeshan M; Saini J; Gupta A; Sandhya M; Pal PK
    Neurol India; 2016; 64(4):633-9. PubMed ID: 27381106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR imaging of brainstem atrophy in progressive supranuclear palsy.
    Slowinski J; Imamura A; Uitti RJ; Pooley RA; Strongosky AJ; Dickson DW; Broderick DF; Wszolek ZK
    J Neurol; 2008 Jan; 255(1):37-44. PubMed ID: 18080856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive supranuclear palsy and idiopathic Parkinson's disease are associated with local reduction of in vivo brain viscoelasticity.
    Lipp A; Skowronek C; Fehlner A; Streitberger KJ; Braun J; Sack I
    Eur Radiol; 2018 Aug; 28(8):3347-3354. PubMed ID: 29460073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M; Diehl-Schmid J; Hapfelmeier A; Kontaxopoulou D; Stefanis L; Oertel WH; Bhatia KP; Papageorgiou SG; Höglinger GU
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midbrain morphology in idiopathic normal pressure hydrocephalus: A progressive supranuclear palsy mimic.
    Constantinides VC; Paraskevas GP; Velonakis G; Toulas P; Stefanis L; Kapaki E
    Acta Neurol Scand; 2020 Apr; 141(4):328-334. PubMed ID: 31856297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy.
    Looi JC; Macfarlane MD; Walterfang M; Styner M; Velakoulis D; Lätt J; van Westen D; Nilsson C
    Psychiatry Res; 2011 Nov; 194(2):163-75. PubMed ID: 21899988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.
    Sakurai K; Tokumaru AM; Shimoji K; Murayama S; Kanemaru K; Morimoto S; Aiba I; Nakagawa M; Ozawa Y; Shimohira M; Matsukawa N; Hashizume Y; Shibamoto Y
    Neuroradiology; 2017 May; 59(5):431-443. PubMed ID: 28386688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.